Luminex, Merck to develop Alzheimer's diagnostic device

03/14/2013 | American City Business Journals · Fox Business

Luminex and Merck & Co. have entered a partnership to develop a diagnostic device for Alzheimer's disease that will be used to screen patients for a clinical trial of Merck's drug candidate MK-8931. The device will assess levels of two potential disease biomarkers in cerebrospinal fluid samples from patients who demonstrate mild cognitive impairment.

View Full Article in:

American City Business Journals · Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ